Application note

Application note: Advancing CAR T-cell therapy with CTS TrueCut Cas9 Protein

Read this free application note where we look at the CTS TrueCut Cas9 Protein, from its detailed quality specifications to its performance in primary T cells.

Advancing cell therapy products to reach the clinic starts with selection of the right reagents. Not only must the reagents be of sufficient quality to comply with rigorous regulatory standards, but they must also be manufactured with scalable processes to meet future clinical demands. Under the GibcoTM Cell Therapy SystemsTM (CTSTM) brand, Thermo Fisher Scientific offers a broad array of high-quality products specifically designed for use in cell therapy research applications. From media, reagents, growth factors and enzymes to selection beads and devices, all Gibco CTS products are manufactured in compliance with the 21 CFR Part 820 quality system regulation and/or are certified to ISO 13485 and ISO 9001. The adherence to stringent quality standards allows for a seamless transition from bench to clinic.